Non-invasive hemodynamic monitoring for babies and children in ICU featuring AcQumen Medical
On today’s episode we speak with Dori Jones , Co-Founder and CEO of AcQumen Medical — a company on a mission to close one of pediatric critical care’s most glaring gaps: the lack of real-time, non-invasive hemodynamic monitoring for babies and children in the ICU.
AcQumen Medical is developing UltraTrack, a first-of-its-kind monitoring platform that combines bioimpedance and ultrasound technology to measure cardiac output, blood flow, and vascular resistance — without an invasive catheter. Built for the smallest and most vulnerable patients, UltraTrack is designed to give clinicians the data they need to intervene earlier.
Dori’s career spans heart pump development, clinical marketing, and commercialization strategy — but it was a deeply personal experience watching her infant son in the ICU, with little more than a pulse oximeter taped to his toe, that crystallized her mission. Dori shares the founding story behind AcQumen Medical, how UltraTrack’s novel combination of bioimpedance and ultrasound is giving pediatric clinicians access to data they’ve never had before, and her vision for where AcQumen Medical goes next.
